Shiga University of Medical Science · Faculty of Medicine

Research keywordshepatocellular carcinoma・atezolizumab plus bevacizumab・cancer immunotherapy・Wnt/beta-catenin signaling・tumor microenvironment・conversion therapy・hyperprogressive disease

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• クリニカルクエスチョンを核とした研修医向け遠隔教育の実践2026 · 医学教育, 2026年02月25日
• Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway.2025 · Clinical and molecular hepatology, 2025年03月11日, 査読有り, 通常論文
• Complete Remission of Acute-onset Autoimmune Hepatitis Following Transcatheter Splenic Arterial Embolization and Splenectomy for Spontaneous Splenic Rupture2025 · Internal Medicine, 2025年,
• No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study.2025 · Cancers, 2025年11月28日

• Official profile